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Abstract
We recently demonstrated the use of in vitro expanded kidney-derived mesenchymal stem cells (KMSC) protected
peritubular capillary endothelial cells in acute renal ischemia-reperfusion injury. Herein, we isolated and characterized
microparticles (MPs) from KMSC. We investigated their in vitro biologic effects on human endothelial cells and in vivo
renoprotective effects in acute ischemia-reperfusion renal injury. MPs were isolated from the supernatants of KMSC cultured
in anoxic conditions in serum-deprived media for 24 hours. KMSC-derived MPs demonstrated the presence of several
adhesion molecules normally expressed on KMSC membranes, such as CD29, CD44, CD73, a4, 5, and 6 integrins.
Quantitative real time PCR confirmed the presence of 3 splicing variants of VEGF-A (120, 164, 188), bFGF and IGF-1 in
isolated MPs. MPs labeled with PKH26 red fluorescence dye were incorporated by cultured human umbilical vein
endothelial cells (HUVEC) via surface molecules such as CD44, CD29, and a4, 5, and 6 integrins. MP dose dependently
improved in vitro HUVEC proliferation and promoted endothelial tube formation on growth factor reduced Matrigel.
Moreover, apoptosis of human microvascular endothelial cell was inhibited by MPs. Administration of KMSC-derived MPs
into mice with acute renal ischemia was followed by selective engraftment in ischemic kidneys and significant improvement
in renal function. This was achieved by improving proliferation, of peritubular capillary endothelial cell and amelioration of
peritubular microvascular rarefaction. Our results support the hypothesis that KMSC-derived MPs may act as a source of
proangiogenic signals and confer renoprotective effects in ischemic kidneys.
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Introduction
Microparticles (MPs) are submicron-size vesicles that carry
membrane and cytoplasmic constituents of the cells they
originated from. They result from plasma membrane remodeling
in response to various stimuli, such as oxidative stress or hypoxia.
[1,2] MPs express specific antigens according to their cellular
origin. [1,3] They also act as vectors of growth factors, such as
VEGF and proteases, according to the specific stimuli that induced
their production. [3,4]
Cell therapy using pluripotent MSCs to treat kidney injury has
been extensively investigated in the past decade.[5–9] Initially, it
was believed that stem cells home to injured tissue and exert their
beneficial effects by differentiating into targets cells and replacing
injured tissue. However, it was subsequently demonstrated that
transplanted stem cells do not replace injured resident cells but
mitigate injury and hasten repair by a paracrine mechanism. [10]
MSCs secreted vasculotrophic growth factors such as VEGF, IGF-
1, or hepatocyte growth factor and these factors contributed to
renal repair. [11] Intravenous infusions of conditioned medium
from cultured MSCs consistently exerted renoprotective effects,
mimicking the beneficial effects of MSC administration and
further supporting the paracrine mechanism of MSC mediated
renoprotection. [12] Recent studies have reported that bone
marrow MSC- or endothelial progenitor cell-(EPC) derived MPs
exert renoprotective effects comparable to those of their origin
cells in various experimental acute and chronic renal injuries by
inhibiting apoptosis and stimulating proliferation of resident renal
cells. [13–15]
MPs derived from human bone marrow MSC were found to
mediate horizontal mRNA transfer that stimulated proliferation
and inhibited apoptosis of tubular epithelial cells in vitro. [14] EPC-
derived MPs also protected kidneys from acute ischemia-reperfu-
sion (I/R) injury by delivering miRNA that contributed to
reprogramming hypoxic resident tubular epithelial and peritubu-
lar capillary endothelial cells to a regenerative program. More-
over, EPC-derived MPs protect against chronic kidney damage
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progression by inhibiting capillary rarefaction, glomerulosclerosis,
and tubulointerstitial fibrosis. [16] They showed that EPC-derived
MPs were efficiently internalized in both peritubular endothelial
cells (TEnCs) and tubular epithelial cells (TEpCs). Moreover, the
in vitro internalization of EPC-derived MPs within hypoxic TEnCs
and TEpCs was followed by reduced apoptosis and enhanced
angiogenesis on Matrigel-coated surfaces. [16]
Our previous study showed that a fibroblast-like cell clone
isolated from adult mouse kidney differentiated along multiple
mesodermal lineages. The kidney-derived MSC (KMSC) migrated
to a peritubular interstitial location and expressed interstitial cell
markers after subcapsular injection into unilateral I/R injuries in
mice kidneys. [17] When in vitro expanded KMSC was injected
into the tail vein of ischemic mice, they engrafted the ischemic
kidney and promoted tubular regeneration and functional
recovery from I/R injury. Compared to controls, KMSC injection
increased renal tissue VEGF expression and improved peritubular
capillary endothelial cell rarefaction. [6]
The aim of the present study was to investigate the character-
istics of KMSC-derived MPs and their in vitro effects on human
endothelial cell viability, apoptosis, and capillary tube formation.
Furthermore, the renoprotective effects of KMSC-derived MPs in
ischemic mice were evaluated via in vivo preservation of peritubu-
lar capillary endothelial cells as well as improvement in renal
function.
Materials and Methods
Mouse Kidney Mesenchymal Stem Cell Cultures and
Microparticles Isolations
In our previous report, we isolated and cloned a fibroblast-like
cell line from the kidney of an adult FVB/N Tie-2/GFP mouse.
[17] The KSMC was cultured on gelatin-coated dishes in
minimum essential medium (MEM) with 10% horse serum
(Gem Biotech, Woodland, CA, USA) to 80% confluence, as
previously described. [17] To generate MPs, KMSC was cultured
in a serum-free alpha-MEM in ,1% O2 using a controlled
atmosphere chamber and O2 analyzer (Thermo Scientific,
Marietta, OH, USA) or KMSC was cultured in a serum-free
alpha-MEM with 200 mM hydrogen peroxide and then placed in
hypoxic chamber (,1% O2) for 24 hours. Cell debris was removed
by centrifugation at 1000 g for 10 min at room temperature. The
cell-free supernatants were centrifuged at 50,000 g (Beckman
Coulter Optima L-90K, Beckman Coulter, Inc. Brea, CA, USA)
for 2 h at 4uC and washed in phosphate-buffered saline (PBS),
followed by a second centrifugation in the same conditions. MPs
were identified by fluorescence microscopy or FACS analysis and
electron microscopy. MPs from KMSC were labeled with PKH26
dye (Sigma) or cell-tracker (Invitrogen) to trace in vivo and in vitro
experiments. MP pellets were suspended in PBS, and FACS
measured the number/ml. Endotoxin contamination of MPs was
excluded by Limulus testing.
Total MP RNA was extracted using an ExoMirTM Kit
according to the manufacturer’s instructions (Charles River
Laboratories, Inc., Wilmington, MA, USA). Briefly, supernatants
were obtained from KMSC after removing debris by centrifuga-
tion at 2000g for 15 min. Supernatant was passed through MP
selective filters. The filters were then flushed with an RNA
extraction reagent to lyse the captured MPs and release their
contents. To abolish the mRNA-dependent effects, MPs were pre-
incubated with 1 U/ml RNase (Ambion Inc., Austin, TX, USA)
for 1 h at 37uC, as previously described (RNase-treated MPs).
[14,18] The reaction was stopped by adding 10 U/ml RNase
inhibitor (Ambion Inc.). The complete degradation of RNA by
RNase treatment was confirmed by analyzing total RNA extracted
from MPs pre-incubated with RNase on 1% agarose gel (data not
shown).
FACS Analysis of MP
MPs were examined by flow cytometry analyses (BD Canto II,
USA). The instrument was rinsed with particle-free rinse solution
for 15 minutes to eliminate the background. Different sized beads
(Mega-mix, 0.5, 0.9, 3 mm, Biocytex, Marsille, France) represented
size markers, and a log scale for forward scatter and side scatter
parameters were used for analysis. FACS analysis was performed
as described previously [14,18,19] using the following FITC- or
PE-conjugated antibodies: CD29, CD44 (BD science), CD73, a4
integrin, a5 integrin, and a6 integrin (Biolegend, San Diego, CA).
FITC- or PE- mouse non-immune isotypic IgG were used as a
control.
Figure 1. Electron microscopy analyses of KMSC-derived microparticles (MPs). Representative micrographs of transmission electron
microscopy obtained upon MP release from the surface of KMSC (A); MPs within larger vesicles in the cell cytoplasm were shown (B). Black bar
represents 1000 nm.
doi:10.1371/journal.pone.0087853.g001
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Incorporation of MPs into HUVEC and Peritubular
Endothelial Cells
To evaluate the incorporation of MPs into human umbilical
vein endothelial cells (HUVEC), MPs were pre-incubated with
PKH 26 dye for 30 min at 37uC. The incorporation was studied
by FACS analyses and immunofluorescence microscopy. The role
of adhesion molecules expressed by KMSC-derived MP surfaces
in target cell incorporation was then investigated. MPs were pre-
incubated (15 min at 4uC) with blocking antibodies (1 mg/ml)
against the identified adhesion molecules such as anti-a4 integrin,
anti-a5 integrin, anti-a6 integrin, anti-CD29, CD44, or trypsin
(0.5mM, Invitrogen) before incubation with the cells.
To investigate previously reported MSC derived-MP mediated
horizontal mRNA transfer, [14,18] KMSC was transfected with
CMV-GFP using lipofectamine (Invitrogen). MPs were isolated
from KMSC 48 hours after transfection. HUVEC was incubated
with MPs isolated from KMSC transfected with GFP or without
GFP. As a positive control, GFP-DNA was used. To investigate
in vivo MP mediated horizontal mRNA transfer, mice received an
intravenous injection of MPs derived from KMSC transfected with
GFP or saline alone into the tail vein after I/R injury. RT-PCR
analysis was performed on total RNA from HUVEC and kidney
tissues. b-actin mRNA was used as a housekeeping gene.
In vitro Cell Proliferation, Apoptosis, and Angiogenesis
Assay
HUVEC was seeded in EBM-2 media (Lonza) deprived of FBS
into 96-well plates at 56103 cells/well. Cell proliferation was
determined by EZ-Cytox cell proliferation assay kit (Daeil Lab
Service Co, Seoul, Korea) according to the manufacturer’s
instructions. Briefly, 20 ml of EZ-Cytox kit reagent was added to
each cell cultured well of a 96-well microplate and then incubated
at 37uC in a humidified CO2 incubator for 3 h. After incubation,
optical density (OD) was measured at a wavelength of 450 nm
using an absorbance microplate reader (BioTek Instruments, Inc.,
Winooski, VT, USA). Apoptosis was evaluated using an apoptosis
kit (Roche, USA) according to the manufacturer’s instructions. In
addition to HUVEC, adult dermis human microvascular vein
endothelial cells (HMVEC, Life technologies, CA USA) were
seeded in Medium 131 (Gibco) into 96-well plates at 56103 cells/
well for apoptosis assay.
In vitro tube formation was studied on HUVEC (26104 cells/
well) seeded on growth factor–reduced Matrigel (BD Science).
After cells were attached, KMSC-derived MPs (2.56106, 56106,
106106/well) and RNase-treated MPs were added. The cells were
observed under a Nikon-inverted microscope (Kanagawa, Japan)
after 6-hour incubation at 37uC. The number of tube formation,
Figure 2. Cytofluorimetric characterization of KMSC (A) and KMSC-derived MPs (B). One mm and 6 mm beads were used as internal size
standards. P1 area was compatible with 1 mm. Red lines indicate the expression of annexin V, CD44, CD73, CD29, a4 integrin, a5 integrin, and a6
integrin surface molecules. Black lines indicate isotypic controls.
doi:10.1371/journal.pone.0087853.g002
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which was defined as combination of tube number and number of
sprouts, was counted by a blinded observer. [20]
Quantitative Real Time PCR
Quantitative real-time PCR was performed on the total RNA
extracted from KMSC and KMSC-derived MPs prepared by
culturing KMSC in a microenvironment mimicking AKI.
First-strand cDNA was produced from total RNA using cDNA
Synthesis Kit (SuperScriptH III First-Strand Synthesis System,
Invitrogen Inc.). Briefly, 1–2 mg RNA, 2 ml RT buffer, 1 ml 10mM
dNTP mixture, 1 ml random hexamer, 2 ml 0.1M DTT, 1 ml
reverse transcriptase, and nuclease-free water were used for each
cDNA synthesis. Twenty microliters of RT-PCR mix containing
ten ml of 2X SYBR GREEN PCR Master Mix (Applied
Biosystems), 100 nM of each primer, and 0.5 ml of MV cDNA
were assembled using a Real Time System (ABI 7900 HT).
Negative cDNA controls (no cDNA) were cycled in parallel with
each run.
The following PCR primers were used for amplification: VEGF
120 forward 59-CCACGTCAGAGAGCAACATCAC-39 and
reverse59- GGCTTGTCACATTTTTCTGGCT-39, VEGF 164
forward 59-AGGATGTCCTCACTCGGATG-39 and reverse 59-
AAAGGACTTCGGCCTCTCTC-39, VEGF 188 forward 59-
GTTCGAGGAAAGGGAAAGGGT-39 and reverse 59-
GTCTGCGGATCTTGGACAAAC-39, IGF1 59- GCT CTG
CTT GCT CAC CTT CAC -39 and reverse 59-GAA TGC TGG
AGC CAT AGC CT- 39, and FGF forward 59-GCG ACC CAC
ACG TCA AAC TA-39 and reverse 59-TCC CTT GAT AGA
CAC AAC TCC TC-39.
Mice Model of AKI
The animal study protocol was in accordance with guidelines
for laboratory animals and approved by the Institutional Animal
Care and Use Committee, Department of Laboratory Animal
Medicine, Medical Research Center, Yonsei University College of
Medicine (2010-0226-1). Adult (8–12 weeks old) FVB/N mice
were purchased from Orientbio (Gyeonggi-Do, Korea) and were
kept under temperature-controlled conditions of 12-h light/dark
cycle, with water and food ad libitum. Mice were anesthetized with
intraperitoneal injection of a combination of zoletil (20 mg/kg)
and xylazine (10 mg/kg), and all efforts were made to minimize
suffering. Bilateral renal ischemia in male FVB/N mice was
performed according to a previously detailed protocol. [6] Mice
were anesthetized followed by midline laparotomy and bilateral
renal pedicle clamping with microserrefines (Fine Science Tools,
Foster City, CA, USA). The abdomen was covered with gauze
moistened in saline. Mice were well hydrated with saline at a
constant temperature using a heated thermoplate (Jeung Do Bio &
Plant Co, Korea) during the ischemia period. The clamps were
released and reperfusion was visually confirmed after 30 min of
ischemia. After I/R injury, mice received an intravenous injection
of MPs from KMSC (2 6 107 per mouse), RNase- treated MP,
KMSC (16106 per mouse) in 150 mL saline, or saline alone into
the tail vein. For each group, mice were killed at day 3 (n= 5 per
group) after I/R injury. Kidney tissues were processed for
morphologic studies. Blood samples for measuring serum creati-
nine were collected before, and at 1 and 3 days after I/R injury
with vehicle control, KMSC or MP. Creatinine concentrations
were determined using a Fuji Dri-Chem 4000i system (Fujifilm,
Japan).
Morphologic Studies
4 mm-thick paraffin kidney sections were stained with PAS for
renal histology. Tubular injury was semiquantitatively scored by a
renal pathologist (BJ Lim), who was blinded to study design, by
assessing the percentage of tubules in the outer medulla and
corticomedullary junction that showed tubular dilatation, atrophy
or cast formation or sloughing of tubular epithelial cells, and
Figure 3. Real-time PCR analysis of mRNA expression of KMSC and KMSC-derived MPs. The relative mRNA expression of vascular
endothelial growth factor (VEGF), insulin-like growth factor (IGF), and fibroblast growth factor (FGF) of KMSC (Figure 3A) and their MPs (Figure 3B) in
normoxic (white bars) and anoxic (black bars) conditions. Results are expressed as mean 6 SE of three different experiments. Kruskal-Wallis test was
performed; * P,0.05 versus normoxia control.
doi:10.1371/journal.pone.0087853.g003
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thickening of tubular basement membrane as follows;; 0, none; 1+,
,10%; 2+, 10–25%; 3+, 26–45%; 4+, 46–75%; 5+, .75% of
tubules. Twenty fields randomly selected from cortex and
corticomedullary junction on each slide section were examined
at6400 magnification, as previously reported. [21,22] Transmis-
sion electron microscopy was also performed on MPs or on
cultured KMSC releasing MPs. The KMSC-MPs engrafted in
peritubular capillaries were detected by colocalizing green
fluorescent CellTrackerTM-labeled MPs within the red fluorescent
CD 31 (Abcam) labeled peritubular capillary endothelial cells by
confocal microscope (LSM 510, Carl Zeiss, Jena Germany) using
6 40 fluorescence objective lens. Green fluorescent CellTrack-
erTM and red fluorescent CD31 double labeled MPs were counted
by examining 20 viewing fields randomly selected from the cortex
and corticomedullary junction on each slide at 6400 magnifica-
tion (the number of MPs/mm2). Immunohistochemistry was
performed to detect the proliferation of peritubular capillary
endothelial cells. Kidney sections were subjected to antigen
retrieval, and slides were blocked and labeled with 1:100 of anti-
CD 31(Abcam) and 1:200 of monoclonal anti-PCNA (Millipore).
Immunoperoxidase staining was performed using a 1:100 dilution
of anti-rabbit HRP (Abcam) or anti-mouse IgM (Invitrogen).
CD31 and PCNA-positive cells were scored by counting the
number of positive nuclei per field in 10 randomly chosen sections
of kidney cortex at 6400 magnification. Quantification of
peritubular capillary loss was determined by the rarefaction index,
as previously described. [6] Briefly, CD31-immunostained sections
were examined through a 10610 grid under a 6 40 objective.
Each square within the grid that did not contain a CD31-positive
capillary was counted. At least twenty fields were examined on a
cross-section of each kidney, and a mean score per section was
calculated. This scoring system inversely reflects peritubular
capillary rarefaction, in which low values represent intact
capillaries and higher values indicate loss of capillaries. Terminal
deoxynucleotidyl transferase-mediated dUTP nick end-labeling
(TUNEL) assays were performed using an In Situ Cell Death
Detection Kit (Roche, Indianapolis, IN, USA) to detect cell
apoptosis in the kidneys. The positive nuclei in the field were
Figure 4. Incorporation of MPs in HUVEC. (A) Immunofluorescence analysis of HUVEC internalization (30 min at 37uC) of MPs labeled with
PKH26 preincubated with or without trypsin (0.5 mM), or with 1 mg/ml blocking monoclonal antibody against CD44, CD29, a4 integrin, a5 integrin,
and a6 integrin. (B) Representative FACS analyses of HUVEC internalization of MPs labeled with PKH26 (black curves) after 30 min of incubation at
37uC. MPs were preincubated with or without trypsin, or with 1 mg/ml blocking monoclonal antibodies against CD44, CD29, a4 integrin, a5 integrin,
and a6 integrin. Black curves indicate internalization of untreated MPs. In the first panel, red curve indicates negative control (cells not incubated with
MPs) and black dot curve indicates PKH 26 expression in cultured HUVEC treated with PKH 26 labeled MPs alone. In other panels, red curves indicate
internalization of MPs in cultured HUVEC after pretreatment with trypsin or blocking antibodies. D denotes the degree of PKH 26 reduction after
treatment with trypsin or blocking antibodies compared to PKH 26 labeled MPs alone. Three independent experiments were performed with similar
results.
doi:10.1371/journal.pone.0087853.g004
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examined for under confocal microscope (LSM 510, Carl Zeiss,
Jena Germany) using 6 40 fluorescence objective lens and
analyzed with LSM5 software. Twenty fields randomly selected
from cortex and corticomedullary junction on each slide section
were examined.
Statistical Analysis
Data are expressed as mean 6 S.E. Differences between groups
were analyzed by Mann-Whitney test or Kruskal–Wallis test using
SPSS 20.0 (SPSS, Chicago, IL, USA). A P value less than 0.05 was
considered statistically significant.
Results
Characterization of KMSC-derived MPs
Transmission electron microscopy demonstrated MPs being
released from the cell surface or within larger vesicles in the
cytoplasm of KMSC (Figure 1A and B). By flow cytometric
analysis, KMSC-derived MPs were mainly detected at a region
below the forward scatter signal corresponding to 1 mm beads,
which were used as internal size standards (Figure 2B). KMSC-
derived MPs positive for Annexin V (86%) and they further
expressed CD44, CD73, CD29, a4 integrin, a5 integrin, and a6
integrin, which were also expressed on KMSC plasma membranes
(Figure 2B). These findings indicate that MPs express several
adhesion molecules of KMSC plasma membranes on their
surfaces. The expression of these adhesion molecules was shown
to be instrumental in incorporating MPs into target cells.
Proangiogenic Gene Expression Analysis of KMSC-
derived MPs
Quantitative real time PCR analysis confirmed the relative
mRNA expression of proangiogenic vascular endothelial growth
factor (VEGF), insulin-like growth factor-1 (IGF-1), and fibroblast
growth factor (FGF) in KMSC and KMSC-derived MPs. KMSC-
derived MP cDNA was prepared from KMSC cultured in both
normoxic and anoxic (,1% O2) environments mimicking I/R
injury. Compared to normoxic conditions, anoxic conditions
induced greater mRNA expression of all VEGF splicing forms
(120, 164, 188) and IGF1 in KMSC (Figure 3A). KMSC-derived
MPs in anoxic conditions demonstrated significantly higher levels
of mRNA expression for VEGF 120, VEGF 188, IGF1, and FGF
(Figure 3B).
Incorporation of KMSC-Derived MPs into HUVEC
To identify the incorporation of KMSC-derived MPs, endo-
thelial cells (HUVEC) were cultured with MPs labeled with PKH
26 dye. Immunofluorescence microscopy and FACS analysis
revealed that PKH 26 labeled MPs were readily incorporated into
cultured HUVEC. The incorporation of PKH 26 labeled MPs was
significantly inhibited by removing surface molecules with trypsin
pretreatment (241.163.7% compared to non-treated control on
FACS analysis) (Figure 4). Furthermore, to investigate the role of
specific surface molecules, PKH26 labeled MPs were pretreated
with 1 mg/ml blocking monoclonal antibodies against CD44,
CD29, and a4, 5, and 6 integrins. Pretreatment with anti-CD44,
CD29, and a4, a5, and a6 integrin antibodies also significantly
Figure 5. In vitro cell proliferation and anti-apoptotic effects of MPs. (A) Proliferation of HUVEC treated with vehicle control, with different
doses of MPs or MP-treated with RNase (MP-RNase). (B) Apoptosis assay of HUVEC treated with vehicle control or with different doses of MPs. (C)
Apoptosis assay of HMVEC treated with vehicle control or with different doses of MPs. Results are expressed as % compared to vehicle control and
mean 6 SE of three different experiments. Kruskal-Wallis test was performed; * P,0.05 versus vehicle control.
doi:10.1371/journal.pone.0087853.g005
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inhibited the incorporation of MPs into cultured HUVEC
compared to non-treated controls (with anti-CD44:
233.564.2%, with anti-CD29: 241.960.5%, with anti-a4:
228.362.5%, with anti-a5: 224.663.3%, with anti-a6:
222.865.2%). These results implied that surface molecules such
as CD44, CD29, and a4, a5, and a6 integrins all play an
important role in the incorporation of KMSC-derived MPs into
HUVEC (Figure 4 A, B).
In vitro Cell Proliferation, Anti-apoptotic, and Angiogenic
Effects of KMSC-derived MPs
Incubation of HUVEC with KMSC-derived MPs promoted a
significant dose-dependent improvement in HUVEC proliferation
in serum deprived culture conditions compared to control cells
incubated with vehicle alone (relative degree of proliferation
according to MP dose 1.256106, 2.56106, 56106; 109.068.3%,
110.3615.1%, 126.8617.0% compared to control, Figure 5A).
When KMSC-derived MPs were pretreated with RNase that
induced complete RNA degradation, the beneficial effect of
KMSC-derived MPs on HUVEC proliferation was significantly
inhibited (Figure 5A). However, MPs did not inhibit the serum
deprivation induced apoptosis of HUVEC in vitro (Figure 5B).
Heterogeneity and differences between large and small vessel
endothelial cells are well known. We therefore, investigated
antiapoptotic effect of MPs on HMVEC, which is of microvascular
origin. In contrast to HUVEC, apoptosis of HMVEC was
significantly inhibited by MPs (relative degree of apoptosis
according to MP dose 1.256106, 2.56106, 56106; 22.863.6%,
17.063.9%, 17.262.8% compared to control, Figure 5 C).
In vitro angiogenic effects of KMSC-derived MPs on HUVEC
were tested. HUVEC was grown on growth factor reduced
Matrigel with or without KMSC-derived MPs. MPs dose-
dependently promoted the endothelial capillary tube formation
of HUVEC (relative degree of tube formations according to MP
dose 2.56106, 56106, 106106; 135.6611.1, 164.9610.8,
175.663.5% compared to control, Figure 6A and B). This
proangiogenic effect of MPs was inhibited by RNase pretreatment
(Figure 6B).
MP-mediated Horizontal mRNA Transfer into HUVEC by
in vitro and in vivo Engraftment of MPs into Peritubular
Kidney Capillaries
KMSC was transiently transfected with green fluorescence
protein (GFP) DNA to assess horizontal transfer of MP mRNA
into target HUVEC. MPs were isolated from KMSC that were
transfected with green fluorescence protein DNA (GFP-MP).
Untreated control HUVEC do not normally express GFP, as
shown by the negative RT-RCR of RNA extracted from control
HUVEC. In contrast, GFP mRNA was readily detected in
HUVEC incubated with GFP-MPs for 6 hours (Figure 7A). This
finding suggests MP-mediated horizontal transfer of GFP mRNA
into target HUVEC in vitro (Figure 7A). Next, we investigated
in vivo MP mediated horizontal mRNA transfer in mice kidney
tissue. GFP mRNA was expressed only in I/R injury kidney
injected with GFP MP via tail vein (Figure 7B).
To examine the engraftment of KMSC-MPs in the kidney,
green CellTrackerTM labeled MPs were injected into I/R injured
FVB/N mice. Mice were sacrificed at day 3 after KMSC-MP
injection and the number of average engrafted MPs was 2.960.3
MPs/mm2 of kidney cortex by semi-quantitative analysis
(Figure 7C). Confocal microscope analysis confirmed the engraft-
Figure 6. In vitro angiogenic effects of MPs. (A) Representative images of angiogenic effects of HUVEC pretreated with vehicle control, with
different doses of MPs, or MPs preincubated with RNase (MP-RNase). (B) Quantitative analysis of tube formation of HUVEC was performed. Results are
expressed as % versus vehicle alone and mean6 SEM of six different experiments. Results are expressed as mean6 SE of three different experiments.
Kruskal-Wallis test was performed; * P,0.05 versus control.
doi:10.1371/journal.pone.0087853.g006
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ment of CellTrackerTM labeled MPs in peritubular capillaries
expressing CD 31 (Figure 7D).
KMSC-derived MPs Protect against I/R Injury in Kidneys
Next, the in vivo renoprotective effects of KMSC-derived MPs
infused in bilateral renal I/R injured mice were investigated.
Thirty minutes of bilateral I/R injury induced severe renal
dysfunction, as demonstrated by a significant increase in serum
creatinine levels. Compared to control ischemic mice, animals that
received KMSC-derived MPs as well as KMSC demonstrated
significantly lower serum creatinine levels at day 3 (1.260.2,
0.960.3 vs.2.960.8 mg/dL, respectively, Figure 8). This result
suggests that KMSC-derived MPs afforded early renoprotection
comparable to that of KMSC transplantation, as shown in our
previous study. To further explore the mechanism of renoprotec-
tion by KMSC-derived MPs, tubular epithelial cell (TEC)
morphology and peritubular capillary microvascular density were
examined. Kidney sections from ischemic mice treated with
KMSC, KMSC-derived MPs, or vehicle and RNase-treated MPs
were stained with PAS and processed for CD31 expression,
respectively. At day 3, the kidneys of mice injected with vehicle or
RNase-treated MPs after I/R injury showed signs of severe tubular
lesions by semi-quantitative injury scoring. Mice kidneys with
injected MSCs or KMSC-derived MPs showed amelioration of
tubular lesions compared to control mice kidneys (4.760.2,
4.260.8 vs. 1.860.4, 1.260.1 scores per HPF (high power field)
(6400), respectively, P,0.05, Figure 9 A, B). The degree of renal
microvascular rarefaction, assessed by CD31 expression, was
significantly reduced in mice injected with KMSC-derived MPs at
3 days after I/R injury compared to mice injected with vehicle or
RNase-treated MPs (42.862.6 vs. 29.562.0 or 22.261.6 per HPF,
respectively, P,0.05) (Figure 10 A, B).
To further examine the renoprotective mechanisms of KMSC-
derived MPs, the degrees of resident renal cell proliferation and
apoptosis were examined in the kidneys of control ischemic and
MP-injected mice. PCNA-positive cells were evaluated by
counting the number of positive nuclei per field in 10 randomly
chosen sections. As shown in Figure 11, the number of PCNA-
positive tubular epithelial cells was significantly greater in mice
kidneys injected with either KMSC or KMSC-derived MPs
compared to mice injected with vehicle or RNase-treated MPs
(16.862.5, 17.061.3 vs. 7.062.0, 6.761.0 cells per HPF,
respectively, P,0.05, Figure 11 A, B). Furthermore, the number
Figure 7. In vitro and in vivo evidence of MP-mediated horizontal transfer of mRNA into HUVEC and confocal microscopic analysis
of engraftment of PKH 26 stained MPs into kidney with I/R injury. (A) RT-PCR analysis for GFP gene in HUVEC. GFP mRNA was detected only
from HUVEC incubated with GFP-MPs, and not from untreated HUVEC. (B) Kidney tissue from I/R injured mice that were administered MPs derived
from GFP transfected KMSC positively expressed.. As a positive control, GFP-DNA was used and b-actin mRNA was used as a housekeeping gene. (C)
The average number of engrafted MPs in mice given intravenous injection of MPs from KMSC. MPs were estimated by observing 20 randomly chosen
fields from cortex and corticomedullary junction. Results are expressed as mean 6 SE. (D) Confocal laser microscopy confirmed green CellTrackerTM
labeled MPs colocalized within peritubular capillaries stained with red fluorescent anti-CD31 in the kidney. White arrows indicate green CellTrackerTM
labeled MPs (upper panel). Yellow arrow indicates the engraftment of green CellTrackerTM labeled MPs in peritubular capillaries. (lower panel). White
bar represents 20 mm.
doi:10.1371/journal.pone.0087853.g007
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of PCNA-positive peritubular capillary endothelial cells was also
significantly greater in I/R injured mice kidneys treated with
either KMSC and KMSC-derived MPs compared to mice injected
with vehicle control or RNase-treated MPs (6.360.7, 6.061.4 vs.
3.260.6, 4.660.5 cells per HPF, respectively, P,0.05, Figure 11
A, C).
The anti-apoptotic effects of MPs on I/R injured kidneys were
evaluated by TUNEL staining. At day 3 after I/R injury, there
were significantly fewer TUNEL positive apoptotic TECs in
kidneys of ischemic mice injected with either KMSC or KMSC-
derived MPs compared to those injected with vehicle or RNase-
treated MPs in confocal microscopic analysis (0.460.2, 0.560.4
vs. 30.064.1, 28.0612.3 cells per HPF, respectively, P,0.05)
(Figure 12 A, B). The apoptotic peritubular capillary endothelial
cells that expressed CD 31 were simultaneously measured with
TUNEL. The total number of TUNEL positive peritubular
capillary endothelial nuclei was also significantly reduced in
kidneys of ischemic mice treated with KMSC or KMSC-derived
MPs compared to mice injected with vehicle control or RNase-
treated MPs (0.260.1, 0.260.2 vs.6.960.7, 3.661.0 cells per
HPF, respectively, P,0.05) (Figure 12 A, C).
These data indicate that in I/R injured mice, injection of
KMSC-derived MPs afforded comparable renoprotective effect to
injecting KMSC alone. This was achieved not only by an effect on
TECs but also by stimulating the proliferation and inhibiting the
apoptosis of peritubular capillary endothelial cells.
Discussion
The present study focused on characterizing the proangiogenic
potential of KMSC-derived MPs and their contribution to
peritubular capillary repair after ischemic injury via horizontal
transfer of genetic materials. The biological characteristics of MPs
are believed to be dependent on activation stimuli or the
Figure 8. Renoprotective effects of KMSC or KMSC-derived
MPs after I/R injury. Mice were given tail vein injections of KMSC,
MPs, or vehicle as control on day 3. Plasma creatinine concentration was
significantly lower in mice treated with KMSC and KMSC-derived MPs 3
days after I/R renal injury. Results are expressed as mean 6 SE of six
different experiments. Kruskal-Wallis test was performed; * P,0.05
versus vehicle control.
doi:10.1371/journal.pone.0087853.g008
Figure 9. Semi-quantitative injury scoring of I/R injury kidney. (A) Representative images of PAS staining in I/R injury kidney with vehicle
control, KMSC, KMSC-derived MPs, and MP-treated with RNase (MP-RNase). (B) Quantitative analysis of I/R injury kidney was determined by semi-
quantitative injury scoring (0–5). Injury score was significantly decreased in kidneys injected with KMSC and KMSC-derived MPs compared to those
injected with vehicle control or MP-RNase 3 days after IRI. Results are expressed as % versus vehicle alone and mean6 SE of six different experiments.
Kruskal-Wallis test was performed; * P,0.05 versus vehicle control. Black bar represents 50 mm.
doi:10.1371/journal.pone.0087853.g009
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microenvironment in which MPs are produced. [2] KMSC in
present study were cultured in serum-free MEM for 24 hours in a
hypoxic chamber to mimic the microenvironment of acute I/R
injury. KMSC-derived MPs generated in this anoxic culture
condition demonstrated significantly higher levels of VEGF-A,
IGF-1 and FGF mRNA compared to those released in normoxic
culture condition. These results implied that there were possible
different properties of MP produced in the ischemic environment
compared to normal, non-stressed conditions. Such increased
expression of proangiogenic MP transcripts in anoxic conditions
may contribute to more efficient regeneration of injured organs
and is clinically relevant as more MPs with proangiogenic
characteristics are needed in time of tissue repair.
VEGF-A is a major player in angiogenesis and is involved in
matrix remodeling, adhesion molecule expression and stimulates
the proliferation of peritubular capillaries that are pivotal for
tubular epithelial cell regeneration. It is alternatively processed in
at least three isoforms in the mouse, which differ in receptor
susceptibility, mitogenic activity, and tissue specific expression.
[23] KMSC-derived MPs generated in anoxic condition showed
all three isoforms with significant increases in the cell-associated
isoform of VEGF-A 188 and its cleaved NH2-terminal fragment
(VEGF-A 120) by real time PCR analysis. [24] An overall
inhibition of the renal VEGF pathway has been observed during
the early time points following I/R injury. The expression of renal
VEGF mRNA is significantly repressed possibly impairing initial
renal vasculature repair and thus contributing to persistent
rarefaction of renal blood vessels. In a rat model of renal
ischemia/reperfusion injury, VEGF mRNA and protein were not
increased. Instead, preexisting VEGF in the tubular cell cytoplasm
redistributed to the basolateral surface thus allowing closer access
to injured endothelial cells. Therefore, delivery of VEGF-A
mRNA via exogenous MPs administration during early post-
ischemic period may contribute to observed in vivo improvements
in renal function and histology, as evidenced by lower serum
creatinine and peritubular capillary rarefaction index. Further-
more, it has been postulated that the differential localization and
balance of proangiogenic growth factors influence the behavior of
the responding endothelium. KMSC-derived MPs also showed the
increased IGF1 and bFGF mRNA, both of which are important in
sustaining stem cell-mediated renal repair and angiogenesis,
suggesting that these MPs are suitable agents of renoprotection
in I/R injury.
Several studies have highlighted renoprotective effects of
administration of MSC as well as MPs derived from bone marrow
MSC in renal injury models. [13–15] The results mainly showed
increase in proliferation or attenuation of tubular epithelial cells
apoptosis. However, little attention was given to rarefaction of
renal vasculature endothelial cells following the I/R injury. Net
shift of growth factors in favor of angiogenesis early post-ischemic
I/R setting may result in vasodilatation and reduction of
vasoconstriction that is important for oxygen delivery to viable
cells and waste product removal from injured tissues. KMSC-
derived MPs stained with PKH26 were found engrafted near the
peritubular capillary area, which in some sections coincided with
CD31 positive cells. KMSC-MP infusion immediately after I/R
injury induced proliferation and inhibited apoptosis of not only
tubular epithelial cells but also peritubular capillary endothelial
Figure 10. Effects of MPs on microvascular rarefaction of I/R injury kidney. (A) Representative images of CD 31 stainings in I/R injury kidney
with vehicle control, KMSC, KMSC-derived MPs, and MP-treated with RNase (MP-RNase). (B) Quantitative analysis of peritubular capillary rarefaction
index was determined by CD31 staining. The degree of microvascular rarefaction was significantly decreased in kidneys injected with KMSC and
KMSC-derived MPs compared to those injected with vehicle control or MP-RNase 3 days after I/R injury. Results are expressed as % versus vehicle
alone and mean 6 SE of six different experiments. Kruskal-Wallis test was performed; * P,0.05 versus vehicle control. Black bar represents 50 mm.
doi:10.1371/journal.pone.0087853.g010
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cells, resulting in better preservation of the peritubular microvas-
culature. Our data are in accordance with a recent study in
ischemic rats that reported improved renal microvascular rare-
faction and preservation of renal function after administration of
EPC-derived MPs. These EPC-derived MPs are well known to
express mRNA and microRNA rich in proangiogenic factors. [16]
Several studies have demonstrated that MPs of stem cell origin
confer renoprotective effects in rodent models of AKI via transfer
of messenger RNA and microRNA to target cells. Pretreatment of
MPs with high concentrations of RNase inactivates mRNAs or
RNAs carried by MPs. We also observed that pretreatment with
RNase significantly reduced the in vitro as well as in vivo effects of
MPs on functional as well as histological alterations of peritubular
capillary endothelial cells induced by I/R injury. These findings
suggest that the horizontal transfer of proangiogenic transcripts
from KMSC-derived MPs to resident renal cells is instrumental in
the renoprotective actions of MPs. Effective mRNA transfer from
KMSC-derived MPs to target endothelial cells was evidenced by
GFP mRNA expression in GFP-MP treated HUVEC and GFP-
MP injected mice kidney with I/R injury.
Another interesting finding of this study is that the in vitro anti-
apoptotic effects of KMSC-derived MPs were different between
the two endothelial cell types, HUVEC and HMVEC. Endothelial
cells from small capillaries differ from those of large veins in their
nutritional requirements and responses to growth stimuli as well as
their angiogenic potential. KMSC-derived MPs significantly
reduced apoptosis of HMVEC, which originates from human
microvasculature, in accord with in vivo findings of decreased
peritubular capillary endothelial cell apoptosis in IRI mice treated
with MPs. HUVEC show different characteristics in the produc-
tion of angiogenic growth factors, extracellular matrix composi-
tion, and proliferation compared to human microvascular
endothelial cells. [25,26] HMVEC have been reported to differ
from HUVEC in the expression of chemokine receptors and other
surface markers. [27,28] Recent study showed different proteome
profiles between HUVEC and HMVEC, which could result in
distinct biological properties and explain their different responses
to KMSC-MPs [29].
In conclusion, the in vivo and in vitro findings of this study suggest
a possible role of KMSC-derived MPs as mediators of renoprotec-
tion that is similar to the paracrine mechanism of renoprotection
observed with KMSC administration in our previous study.
Further studies on the mechanism of proangiogenic MPs
formation and factors determining their biologic characteristics
are needed to refine the future therapeutic potential of MPs in
acute renal ischemia.
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